Literature DB >> 15886801

Lipoprotein (a) and other prothrombotic risk factors in Caucasian women with unexplained recurrent miscarriage. Results of a multicentre case-control study.

Manuela Krause1, Barbara Sonntag, Robert Klamroth, Achim Heinecke, Carola Scholz, Claus Langer, Inge Scharrer, Robert R Greb, Arnold von Eckardstein, Ulrike Nowak-Göttl.   

Abstract

From 1998 to 2003, 133 Caucasian women aged 17-40 years (median 29 years) suffering from unexplained recurrent miscarriage (uRM) were consecutively enrolled. In patients and 133 age-matched healthy controls prothrombotic risk factors (factor V (FV) G1691A, factor II (FII) G20210A, MTHFR T677T, 4G/5G plasminogen activator inhibitor (PAI)-1, lipoprotein (Lp) (a), protein C (PC), protein S (PS), antithrombin (AT), antiphospholipid/anticardiolipin (APA/ACA) antibodies) as well as associated environmental conditions (smoking and obesity) were investigated. 70 (52.6%) of the patients had at least one prothrombotic risk factor compared with 26 control women (19.5%; p<0.0001). Body mass index (BMI; p=0.78) and smoking habits (p=0.44) did not differ significantly between the groups investigated. Upon univariate analysis the heterozygous FV mutation, Lp(a) > 30 mg/dL, increased APA/ACA and BMI > 25 kg/m(2) in combination with a prothrombotic risk factor were found to be significantly associated with uRM. In multivariate analysis, increased Lp(a) (odds ratio (OR): 4.7/95% confidence interval (CI): 2.0-10.7), the FV mutation (OR:3.8/CI:1.4-10.7), and increased APA/ACA (OR: 4.5/CI: 1.1-17.7) had independent associations with uRM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15886801     DOI: 10.1160/TH04-08-0519

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

1.  [Multiple thrombophilic risk markers in patients ≺65 years of age with retinal vein occlusion].

Authors:  C Kuhli-Hattenbach; P Hellstern; W Miesbach; T Kohnen; L-O Hattenbach
Journal:  Ophthalmologe       Date:  2017-12       Impact factor: 1.059

2.  Association of Apo(a)isoform size with dyslipoproteinemia in male venous thrombosis patients.

Authors:  Marian C Cheung; John J Albers; Hal Kennedy; Hiroshi Deguchi; Darlene J Elias; Patricia M Averell; John H Griffin; Santica M Marcovina
Journal:  Clin Chim Acta       Date:  2010-05-19       Impact factor: 3.786

3.  Association of the R67X and W303X non-sense polymorphisms in the protein Z-dependent protease inhibitor gene with idiopathic recurrent miscarriage.

Authors:  F S AlShaikh; R R Finan; A W Almawi; F E Mustafa; W Y Almawi
Journal:  Mol Hum Reprod       Date:  2011-10-27       Impact factor: 4.025

4.  Association of a methylene tetrahydrofolate reductase C677T polymorphism with several blood chemical levels in a Chinese population.

Authors:  Can Wen; Jiao-Feng Lv; Ling Wang; Wei-Feng Zhu; Fu-Sheng Wan; Xiao-Zhong Wang
Journal:  Genet Test Mol Biomarkers       Date:  2015-01

5.  Selective thrombophilia screening of patients with nonarteritic anterior ischemic optic neuropathy.

Authors:  Claudia Kuhli-Hattenbach; Inge Scharrer; Marc Lüchtenberg; Lars-Olof Hattenbach
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-11       Impact factor: 3.117

6.  Interactions between genetic variants involved in the folate metabolic pathway and serum lipid, homocysteine levels on the risk of recurrent spontaneous abortion.

Authors:  Zhong Lin; Qianxi Li; Yifan Sun; Jingchun Huang; Wan Wang; Jinjian Fu; Jianhua Xu; Dingyuan Zeng
Journal:  Lipids Health Dis       Date:  2019-06-15       Impact factor: 3.876

Review 7.  A Novel Review of Homocysteine and Pregnancy Complications.

Authors:  Chuce Dai; Yiming Fei; Jianming Li; Yang Shi; Xiuhua Yang
Journal:  Biomed Res Int       Date:  2021-05-06       Impact factor: 3.411

Review 8.  Lipoprotein(a): An underrecognized genetic risk factor for malignant coronary artery disease in young Indians.

Authors:  Enas A Enas; Basil Varkey; T S Dharmarajan; Guillaume Pare; Vinay K Bahl
Journal:  Indian Heart J       Date:  2019-05-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.